• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The features and functions of influenza B virus BM2 protein in the process of virus particle formation.

Research Project

Project/Area Number 13670310
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Virology
Research InstitutionNational Institute of Infectious Diseases

Principal Investigator

ODAGIRI Takato  National Institute of Infectious Diseases, Department of Virology3, Head, ウイルス第3部, 室長 (80177237)

Co-Investigator(Kenkyū-buntansha) IMAI Masaki  National Institute of Infectious Diseases, Department of Virology3, ウイルス第3部, 研究院 (30333363)
WATANABE Sinji  National Institute of Infectious Diseases, Department of Virology3, ウイルス第3部, 研究院 (30332365)
Project Period (FY) 2001 – 2002
Project Status Completed (Fiscal Year 2002)
Budget Amount *help
¥3,600,000 (Direct Cost: ¥3,600,000)
Fiscal Year 2002: ¥1,300,000 (Direct Cost: ¥1,300,000)
Fiscal Year 2001: ¥2,300,000 (Direct Cost: ¥2,300,000)
Keywordsinfluenza B virus / BM2 protein / cytoplasmic transport / type III membrane protein / trans golgi network / ヌクレオカプシド複合体 / 細胞内輸送
Research Abstract

A bicistronic mRNA transcribed from the influenza B virus RNA segment 7 encodes two viral proteins, matrix protein M1 and uncharacterized small protein BM2. Our previous findings indicate that BM2 is synthesized as a phosphoprotein at the late phase of infection, transported from the perinuclear region to the plasma membrane, and finally incorporated into the virion. In the present study, we focused on the cytoplasmic transport and cellular membrane association of BM2. Immunofluorescence studies of virus-infected and BM2 expression plasmid-transfected cells indicated that BM2 accumulated at the Golgi apparatus immediately after synthesis and then was transported to the plasma membrane through the trans-Golgi network. Localization of a set of BM2 deletion mutants revealed that the N-terminal half of BM2 (residues 2-50) was crucial for its transport ; in particular, the deletion of residues 2-23, deduced to be a transmembrane domain, resulted in diffused distribution of protein throughout the entire cells. Sucrose gradient flotation of the membrane showed that BM2 alone can associate with cellular membranes. Biochemical analysis of the membranes expressing BM2 further indicated that BM2 was tightly associated with cellular membranes as an integral membrane protein. Oligomerization of BM2 was demonstrated by co-precipitation of differentially epitope-tagged BM2 proteins. Furthermore, proteolytic analysis of the purifed virion showed that most part of the BM2 molecule exists in the interior of the virion. Taken together, these results strongly suggest that BM2 is integrated into the plasma membrane at the N-terminal hydrophobic domain in similar fashion to small proteins M2 and NB of influenza A and B viruses, respectively.

Report

(3 results)
  • 2002 Annual Research Report   Final Research Report Summary
  • 2001 Annual Research Report
  • Research Products

    (14 results)

All Other

All Publications (14 results)

  • [Publications] 小田切 孝人: "インフルエンザウイルス株サーベイランスの現状と問題点"インフルエンザ. 3. 45-52 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 小田切 孝人: "インフルエンザウイルス対策-サーベイランス状況も踏えて"化学療法の領域. 18. 1735-1740 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 小田切 孝人: "インフルエンザウイルスの世界の動向と今冬の日本の予測"The Medical Test Journal. 836. 5 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 小田切 孝人: "感染症サーベイランスからわかること"臨床と研究. 79. 2140-2144 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Odagiri, T., Kariwa, H., and Ohara, Y.: "The influenza B virus BM2 protein may be involved in the ribonucleoprotein complexes through the binding with membrane protein M1"International Congress Series. 1219. 411-419 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Obuchi,M., Odagiri,T., Asakura, K. and Ohara, Y.: "Association of L^* protein of Theiler's murine encephalomyelitis virus with microtubules in Infected cells"Virology. 89. 95-102 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 小田切 孝人: "インフルエンザウイルス株サーベイランスの現状と問題点"インフルエンザ. 3. 45-52 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 小田切 孝人: "インフルエンザウイルス対策-サーベイランス状況も踏まえて"化学療法の領域. 18. 1735-1740 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 小田切 孝人: "インフルエンザウイルスの世界の動向と今冬の日本の予測"The Medical Test Journal. 836. 5 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 小田切 孝人: "感染症サーベイランスからわかること"臨床と研究. 79. 2140-2144 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Odagiri, T: "The influenza B virus BM2 protein may be involved in the ribonucleoprotein complexes through the binding with membrane protein M1"International Congress Series. 1219. 411-419 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Obuchi, M.: "Association of L^* protein of Theiler s murine encephalomyelitis virus with microtubules in infected cells"Virology. 289. 95-102 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] 小田切孝人: "インフルエンザワクチン株とワクチンの効果"MEDICO. 32. 321-325 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] 小田切孝人: "インフルエンザウイルス株サーベイランスの現状と問題点"インフルエンザ. 3. 45-52 (2002)

    • Related Report
      2001 Annual Research Report

URL: 

Published: 2001-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi